InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery

Launched by PAUL E. MATUSZEWSKI · Aug 31, 2023

Keywords

ClinConnect Summary

The InterTAN clinical trial is exploring how a new type of screw design, called the InterTAN, can improve recovery for people who have suffered unstable hip fractures. This study aims to understand how well patients can walk and return to their daily activities after surgery. The researchers believe that using the InterTAN may lead to less pain after the operation, help patients walk normally sooner, and enable them to get back to their usual activities more quickly compared to standard treatment methods.

To participate in this trial, candidates must have certain types of hip fractures and should have been able to walk independently before their injury. Unfortunately, those with chronic pain issues, certain neurological conditions, or who need help moving around will not be eligible. If you qualify and choose to take part, you will be closely monitored during your recovery to see how well the new treatment works for you. This trial is not open for enrollment yet, but it's an important step toward improving care for hip fracture patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Non-pathologic fractures
• • OTA/AO classification 31A2, 31A3 fractures
• • Ability to participate in 4-MET equivalent activities without ambulatory assistance prior to injury
• Exclusion Criteria:
• • Inability to consent
• • Inability to participate in follow-up activities
• • History of chronic pain / current opioid treatment
• • Pre-injury ambulatory status requiring assistance device
• • Neurological condition altering gait or sensation (e.g. History of stroke with altered gait, peripheral neuropathy).